Analyst Price Targets — ADIL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 3, 2026 11:03 am | James Molloy | Industrial Alliance Securities | $11.00 | $3.34 | TheFly | Adial Pharmaceuticals initiated with a Buy at Alliance Global |
| June 15, 2026 10:05 am | Elemer Piros | Loop Capital Markets | $6.00 | $2.98 | StreetInsider | Lucid Capital Markets Starts Adial Pharmaceuticals Inc (ADIL) at Buy |
| February 11, 2026 1:42 pm | — | UBS | $8.00 | $3.16 | TheFly | Adial Pharmaceuticals price target lowered to $8 from $37.50 at Maxim |
Latest News for ADIL
GLEN ALLEN, Va., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company's Compensation Committee has granted a new employee stock option to purchase 307,814 shares of common stock as an inducement to such person becoming an employee of the Company.
Completed acquisition of Azora Therapeutics, adding AT177, a fully synthetic, oral, colon-targeted aryl hydrocarbon receptor (“Ahr”) agonist in development for ulcerative colitis, to its pipeline
GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company's Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company's newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company…
- Acquisition of Azora and concurrent private placement positions the combined company to advance its pipeline through key clinical milestones in ulcerative colitis, including Phase 1 initiation in mid-2027
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ADIL.
U.S. House Trading
No House trades found for ADIL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.